Infliximab therapy in patients with secondary Sjögren's syndrome: functional evaluation.
Martin Martin
L S
LS
Migliore
A
A
Todino
V
V
Pagano
A
A
Chianelli
M
M
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000175:diagnosis; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008875:Middle Aged; D011877:Radionuclide Imaging; D020127:Recovery of Function; D012469:Salivary Glands / Q000000981:diagnostic imaging / Q000187:drug effects; D012494:Sampling Studies; D012720:Severity of Illness Index; D012859:Sjogren's Syndrome / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000069285:Infliximab